BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22363420)

  • 1. Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting.
    D'Agata EM; Horn MA; Ruan S; Webb GF; Wares JR
    PLoS One; 2012; 7(2):e30170. PubMed ID: 22363420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and control of hospital-acquired infections with multidrug-resistant organism: A review.
    Ji B; Ye W
    Medicine (Baltimore); 2024 Jan; 103(4):e37018. PubMed ID: 38277558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study.
    Pogorzelska M; Stone PW; Larson EL
    Am J Infect Control; 2012 Oct; 40(8):696-700. PubMed ID: 23021413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial.
    Mody L; Gontjes KJ; Cassone M; Gibson KE; Lansing BJ; Mantey J; Kabeto M; Galecki A; Min L
    JAMA Netw Open; 2021 Jul; 4(7):e2116555. PubMed ID: 34269807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?
    Mody L; Washer LL; Kaye KS; Gibson K; Saint S; Reyes K; Cassone M; Mantey J; Cao J; Altamimi S; Perri M; Sax H; Chopra V; Zervos M
    Clin Infect Dis; 2019 Nov; 69(11):1837-1844. PubMed ID: 30980082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.
    Bearman G; Rosato AE; Duane TM; Elam K; Sanogo K; Haner C; Kazlova V; Edmond MB
    Infect Control Hosp Epidemiol; 2010 May; 31(5):491-7. PubMed ID: 20350197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant organisms in paediatric palliative care patients - Prevalence, risk factors and the impact of a liberal hygiene concept.
    Schmidt P; Hasan C; Mauritz MD; Simon A; Stening K; Hartenstein-Pinter A; Zernikow B; Wager J
    J Paediatr Child Health; 2022 Aug; 58(8):1352-1358. PubMed ID: 35426461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated tracking and ordering of precautions for multidrug-resistant organisms.
    Quan KA; Cousins SM; Porter DD; Puppo RA; Huang SS
    Am J Infect Control; 2015 Jun; 43(6):577-80. PubMed ID: 25681303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a full-time infection control nursing service in the prevention of multidrug-resistant organism in the orthopedic ward.
    Yang Y; Tang TT; Lin J; Gan CL; Huang WZ; Fang Y
    BMC Infect Dis; 2022 Apr; 22(1):348. PubMed ID: 35392833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
    Birgand G; Mutters NT; Ahmad R; Tacconelli E; Lucet JC; Holmes A;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):33. PubMed ID: 32059746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
    Vaillant L; Birgand G; Esposito-Farese M; Astagneau P; Pulcini C; Robert J; Zahar JR; Sales-Wuillemin E; Tubach F; Lucet JC;
    Antimicrob Resist Infect Control; 2019; 8():173. PubMed ID: 31749961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).
    Hur EY; Jin YJ; Jin TX; Lee SM
    J Hosp Infect; 2018 Feb; 98(2):202-211. PubMed ID: 28807836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance at the time of hospital admission for multidrug-resistant microorganisms among patients who had recently been hospitalized at health care facilities.
    Yoon YK; Ryu JM; Lee MJ; Lee SE; Yang KS; Lee CK; Kim MJ; Sohn JW
    Am J Infect Control; 2019 Oct; 47(10):1188-1193. PubMed ID: 31122673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policies for Controlling Multidrug-Resistant Organisms in US Healthcare Facilities Reporting to the National Healthcare Safety Network, 2014.
    Weiner LM; Webb AK; Walters MS; Dudeck MA; Kallen AJ
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1105-8. PubMed ID: 27350394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey.
    Apisarnthanarak A; Khawcharoenporn T; Mundy LM
    Am J Infect Control; 2013 May; 41(5):416-21. PubMed ID: 23098775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes.
    Gontjes KJ; Gibson KE; Lansing BJ; Mantey J; Jones KM; Cassone M; Wang J; Mills JP; Mody L; Patel PK
    JAMA Netw Open; 2022 Feb; 5(2):e2144959. PubMed ID: 35103795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant organisms in allogeneic hematopoietic cell transplantation.
    Heidenreich D; Kreil S; Nolte F; Hofmann WK; Miethke T; Klein SA
    Eur J Haematol; 2017 May; 98(5):485-492. PubMed ID: 28135011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention to reduce transmission of resistant bacteria in intensive care.
    Huskins WC; Huckabee CM; O'Grady NP; Murray P; Kopetskie H; Zimmer L; Walker ME; Sinkowitz-Cochran RL; Jernigan JA; Samore M; Wallace D; Goldmann DA;
    N Engl J Med; 2011 Apr; 364(15):1407-18. PubMed ID: 21488763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.
    Ballo O; Tarazzit I; Stratmann J; Reinheimer C; Hogardt M; Wichelhaus TA; Kempf V; Serve H; Finkelmeier F; Brandts C
    PLoS One; 2019; 14(1):e0210991. PubMed ID: 30673776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.